Date: 5 August, 2026
As Europe stands at a pivotal juncture in public health policy, the European Respiratory Society (ERS) and the European Lung Foundation (ELF) have issued a unified call to action. From 28 September to 4 October 2026, the continent will observe its inaugural EU Screening Week—a high-profile initiative designed to transition from reactive treatment to proactive, preventative healthcare.
The ERS and ELF are spearheading a mission to ensure that respiratory health is not sidelined in this broader cardiovascular-focused effort. By inviting respiratory professionals, patient advocacy groups, and community stakeholders to host local lung health testing events, the organizations hope to demonstrate that the heart and lungs are inextricably linked, and that early detection of respiratory dysfunction is a cornerstone of a healthy, productive European population.
The Strategic Imperative: Why Lung Health Matters Now
The inaugural EU Screening Week is more than just a calendar event; it is a calculated effort by the European Commission to standardize preventative care across its Member States. While the primary impetus originated from the Commission’s cardiovascular health plan, the ERS and ELF have astutely identified that respiratory and cardiovascular health are two sides of the same coin.
Chronic respiratory conditions, such as COPD, asthma, and interstitial lung diseases, place a significant burden on the European economy and individual quality of life. By embedding lung health checks into the broader screening framework, the respiratory community aims to achieve a "game-changing" shift: moving lung function assessment from specialized clinics into the realm of routine primary care.
Chronology of the Initiative
The journey toward this landmark week has been one of persistent advocacy and scientific refinement.
- Pre-2026: The ERS and ELF, through their long-standing "Healthy Lungs for Life" campaign, have spent over a decade gathering data and building public engagement. This period served as the pilot phase for community-based screening, proving that small-scale local interventions can yield significant public awareness dividends.
- Early 2026: The European Commission announces the inaugural EU Screening Week as a pillar of its updated cardiovascular health strategy, inviting various health sectors to participate.
- August 2026: ERS and ELF officially launch their recruitment drive, calling for respiratory professionals and patient networks to register their own events.
- 20 September 2026: The deadline for organizations to register their activities on the official European Commission platform to ensure they appear on the interactive European map.
- 28 September – 4 October 2026: The official window for EU Screening Week, during which hundreds of community-based activities will take place across the continent.
Supporting Data and the "Healthy Lungs for Life" Model
The effectiveness of this week-long initiative relies on the proven methodologies established by the "Healthy Lungs for Life" campaign. For over ten years, this initiative has acted as a bridge between scientific research and public outreach.
Evidence-Based Public Engagement
The campaign leverages clinical evidence to highlight the importance of early detection. Lung function tests, such as spirometry, are simple yet powerful tools that can identify airflow limitation long before severe symptoms emerge. By bringing these tests into community settings—shopping centers, town squares, and local community centers—the ERS and ELF remove the "white coat" barrier that often deters individuals from seeking medical advice.
The Toolkit for Success
To facilitate widespread participation, the ERS and ELF have provided a comprehensive Event Toolkit. This resource is designed to empower local organizers, regardless of their experience in public event management. It includes:
- Standardized protocols for lung health screenings.
- Educational materials for patient counseling.
- Templates for media outreach to ensure local events gain maximum visibility.
The goal is to ensure that "Healthy Lungs for Life" is not an isolated effort but a scalable model that can be replicated in diverse cultural and clinical settings across the EU.
Official Perspectives: A Call for Unified Action
The leadership of the ERS is acutely aware that the success of this initiative rests on the "boots on the ground"—the doctors, nurses, and patients who will perform the screenings and educate the public.
Insights from Prof. Raquel Duarte
Prof. Raquel Duarte, the incoming ERS Director of Scientific Relations with the EU, emphasizes that this initiative represents a critical moment for the respiratory community.
"Prevention of respiratory diseases is at an extremely crucial moment," Prof. Duarte stated. "We are edging ever closer to ensuring that respiratory health checks form part of standardised health checks across Europe, but we need the help of our networks of professionals and patients to make it happen."
Prof. Duarte argues that the integration of respiratory health into the European Commission’s cardiovascular plan would yield immense benefits. "The benefits to public health, and to national and regional economies, would be vast," she noted. She challenged the community to look beyond the "awareness event" label, urging participants to view each registered screening as a data point that will help justify policy shifts at the European level.
"Now is the time for us to all work together and truly demonstrate the importance of early detection," she added. "Each event, no matter how small or large, contributes to our ultimate objective: making respiratory testing a routine, accepted, and accessible part of life for all European citizens."
The Broader Implications: Beyond the Awareness Campaign
The primary ambition of the 2026 EU Screening Week is to evolve from a "one-off" awareness moment into a permanent, institutionalized facet of European healthcare. The organizers are wary of "awareness fatigue," where campaigns generate temporary interest but fail to produce systemic change.
The Economic Case for Screening
Early detection of respiratory conditions significantly reduces the long-term cost of care. Chronic respiratory diseases often lead to hospitalizations, loss of productivity, and premature retirement. By identifying high-risk individuals—such as those exposed to occupational hazards or those with undiagnosed airflow limitations—healthcare systems can intervene earlier, using less invasive treatments to maintain patient health.
Standardizing Respiratory Health
The ultimate goal of the ERS and ELF is to see lung health checks become as routine as blood pressure screenings. By creating a visible, synchronized moment of action across all EU Member States, the ERS and ELF are providing the Commission with tangible evidence that the infrastructure for such screening is already in place, driven by the professional community itself.
Global Impact
If the EU can successfully model this integrated approach to screening, it may well serve as a blueprint for other regions, including the WHO European Region and beyond. The collaborative nature of the initiative—connecting the European Commission, professional societies, and patient-led networks—creates a robust framework for health advocacy that is difficult to ignore.
How to Get Involved
The window for participation is narrow, and the urgency is high. The ERS and ELF have made the registration process straightforward to ensure that even the smallest clinics or local patient groups can contribute to the continental map.
- Plan: Identify your target demographic and the type of activity that best suits your resources (e.g., lung function testing, educational workshops, or community awareness drives).
- Download: Utilize the Healthy Lungs for Life toolkit to structure your event.
- Register: Submit your event details through the official European Commission platform before the 20 September deadline.
By registering, your event will be formally recorded on the European Commission’s interactive map, contributing to a high-visibility, pan-European dataset that will be used to influence future EU health policy.
As September approaches, the message is clear: the future of respiratory health in Europe will not be decided solely in government offices, but in the community clinics and public spaces where citizens are empowered to take their first, crucial steps toward better, clearer breathing. The success of EU Screening Week 2026 rests on the participation of the respiratory community—a community that has waited long enough for lung health to be given the priority it deserves.
